Hazel O'Connor is currently the Senior Director at Orchard Therapeutics, showcasing a wealth of experience in technical operations, business operations, strategy, and alliance management. Prior to their current role, Hazel held leadership positions at Lonza, Hazel O'Connor Consultancy Limited, Terumo BCT, Actavis, NDA Analytics, and Emergent BioSolutions. With a background in Applied Biological Science, Hazel has demonstrated expertise in project and program management, analytical development, and manufacturing assay development throughout their career.
March 1, 2024 - present
June, 2022
May, 2020